Hydrogels as advanced therapeutic delivery systems for improved cancer immunotherapy: current progress, challenges, and future prospects

Authors:

Abstract
This article summarizes recent advances in engineered hydrogels as local depots for the delivery of multiple immunotherapeutics and as a platform for immune-based combination therapy, demonstrating their pivotal roles in the cancer immune cycle.
Funding Information
  • National Natural Science Foundation of China (U23A2070)

This publication has 164 references indexed in Scilit: